Efficacy of immune checkpoint inhibitors in older patients with non-small cell lung cancer: Real-world data from multicentric cohorts in Canada and France

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 28.6K citations

Surgical Oncology, Recist Guideline, Medicine +9

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson et al. · New England Journal of Medicine · 2016 · 9.8K citations · Full text

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

Matthew D. Hellmann, Tudor–Eliade Ciuleanu, Adam Płużański et al. · New England Journal of Medicine · 2018 · 3.1K citations · Full text

Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age

Wendy W. Pang, Elizabeth Price, Debashis Sahoo et al. · Proceedings of the National Academy of Sciences · 2011 · 975 citations · Full text

Aging, Young Hsc, Adult Stem Cell +17

Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations

Lore Decoster, Katrien Van Puyvelde, Supriya G. Mohile et al. · Annals of Oncology · 2014 · 747 citations · Full text

Siog Recommendations, Geriatric Oncology, Aging +12